PRISM MediaWire

PRISM MarketView

Biodexa Pharmaceuticals Reports 12-Month Survival in Glioblastoma Patients

New York, February 09, 2024 - PRISM MarketView - Biodexa Pharmaceuticals (Nasdaq: BDRX) has provided survival updates from its clinical study of MTX110 in patients with recurrent glioblastoma (“rGBM”). Currently, no standard of care is established for rGBM.

9 February 2024

PRISM MarketView

AIM ImmunoTech Tackles Post-COVID Fatigue

New York, February 09, 2024 - PRISM MarketView - AIM ImmunoTech (NYSE American: AIM) has reported positive topline results from a Phase 2 study evaluating the efficacy and safety of Ampligen® as a potential therapeutic for people with the Post-COVID condition of fatigue...

9 February 2024

PRISM MarketView

Cronos Group’s Spinach® Brand Cannabis Takes Top Spot in Canada

New York, February 08, 2024 - PRISM MediaWire - Innovative global cannabinoid company, Cronos Group’s (Nasdaq: CRON), Spinach brand has emerged as the top contender in Canada’s burgeoning cannabis market, securing the coveted position of the number one flower brand in th...

8 February 2024

PRISM MarketView

GrowGeneration Celebrates Drip Hydro’s Innovative Nutrient Line for Cannabis Cultivation

New York, February 08, 2024 - PRISM MediaWire - Drip Hydro has shaken up the cannabis cultivation industry with the introduction of its innovative powder nutrient line, designed specifically to optimize plant health and crop quality. This game-changing product marks a s...

8 February 2024

PRISM MarketView

Microbot Medical Takes Step Towards Human Clinical Trial in US

New York, February 08, 2024 - PRISM MediaWire - Surgical robotics company, Microbot Medical (Nasdaq: MBOT) has taken an important step closer to initiating a pivotal human clinical trial in the United States with the filing of an Investigational Device Exemption (IDE) ap...

8 February 2024

PRISM MarketView

John Madden’s “BOOM-Worthy” Stock Picks and Playbook for Blitzing Sunday’s Super Bowl Party

New York, February 07, 2024 - PRISM MediaWire - PRISM MarketView - On Sunday night, Super Bowl LVIII will be taking place in Las Vegas as the Kansas City Chiefs match up against the San Francisco 49ers. While this match up doesn’t seem to excite most anyone in the other ...

7 February 2024

PRISM MarketView

Biotech Breakfast – Healthcare Equities Outperform; Alto Neuroscience and Fractyl Health IPO; Tyra Biosciences, ImmunityBio Surge

New York, February 05, 2024 - PRISM MarketView - Healthcare equities outperformed last week with Managed Care a standout. The S&P 500 Healthcare Index gained +1.98% versus the S&P 500 Index which was up +1.38%. The week was more difficult for Biotech, MedTech, Se...

5 February 2024

PRISM MarketView

Are We Investing Enough in Vaccine Development?

New York, February 02, 2024 - PRISM MarketView - Vaccination is one of the top 10 most significant public health achievements of the 20th century and remains the most effective preventive measure against infectious diseases. Diseases such as smallpox and polio, which can...

3 February 2024

PRISM MarketView

PRISM MarketView Marks World Cancer Day

New York, February 01, 2024 - PRISM MediaWire - PRISM MarketView, a leading provider of unbiased market insight and company news, today recognizes the tremendous contributions of companies striving to develop treatments for cancer, a complex disease driven by numerous fa...

1 February 2024

Medical Devices

SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference

Remote coronary artery suturing performed on animal model via SS Innovations’ telesurgery platform

1 February 2024